Summary
In the present study Amflamine and other related reversible monoamine oxidase-A (MAO-A) inhibitory phenylalkylamines were examined in vitro for their ability to induce release of 3H-5-hydroxytryptamine (3H-5-HT) from rat occipital cortex slices. The slices were preincubated with 3H-5-HT 0.1 μmol/l in the presence of the irreversible MAO inhibitor pargyline 50 μmol/l and then continuously superfused. The effects were compared with those of the 5-HT releaser p-chloroamphetamine (pCA), the reversible MAO-inhibitor α-ethyltryptamine and the 5-HT uptake inhibitor citalopram. Amiflamine, some related compounds and α-ethyltryptamine which in vivo after transport by the 5-HT uptake mechanism preferentially inhibit MAO within the serotonergic neurons caused a Cat2+-independent release of 3H-5-HT. Some transported compounds, particularly NBF 027 were, however, very weak releasers of 5-HT. This release and that induced by pCA was prevented by citalopram in the superfusion medium. FLA 365, FLA 417 and FLA 1088, which are not transported into the neurons, were poor releasers of 5-HT. It is concluded that compounds which were effective releasers of 5-HT in vitro were those that are transported into the serotonergic neurons by the 5-HT carrier in vivo and has in addition an ability to mobilise vesicular 5-HT.
Similar content being viewed by others
References
Ask A-L, Hellström W, Norrman S, Ögren S-O, Ross SB (1982a) Selective inhibition of the A form of monoamine oxidase by 4-dimethylamino-α-methylphenylalkylamine derivatives in the rat. Neuropharmacology 21:299–308
Ask A-L, Högberg K, Schmidt L, Kiessling H, Ross SB (1982b) (+)-4-Dimethylamino-2,α-dimethylphenethylamine (FLA 336(+)), a selective inhibitor of the A form of monoamine oxidase in the rat brain. Biochem Pharmacol 31:1401–1406
Ask A-L, Fagervall I, Ross SB (1983) Selective inhibition of monoamine oxidase in monoaminergic neurons in the rat brain. Naunyn-Schmiedeberg's Arch Pharmacol 324:79–87
Ask A-L, Fagervall I, Florvall L, Ross SB, Ytterborn S (1985) Inhibition of monoamine oxidase in 5-hydroxytryptaminergic neurones by substituted p-aminophenylalkylamines. Br J Pharmacol 85:683–690
Ask A-L, Fagervall I, Florvall L, Ross SB, Ytterborn S (1986) Selective inhibition of monoamine oxidase by p-amino-substituted phenylalkylamines in catecholaminergic neurones. Neuropharmacology 25:33–40
Ask A-L, Ross SB (1987) Inhibition of 5-hydroxytryptamine accumulation and deamination by substituted phenylalkylamines in hypothalamic synaptosomes from normal and reserpine-pretreated rats. Naunyn-Schmiedeberg's Arch Pharmacol 336: 591–596
Bönisch H, Trendelenburg U (1988) The mechanism of action of indirectly acting sympathomimetic amines. In: Trendelenburg U, Weiner N (eds) Handbook of experimental pharmacology, vol 90/1. Springer, Berlin Heidelberg New York Tokyo, pp 247–277
Chesselet MF (1984) Presynaptic regulation of neurotransmitter release in the brain. Facts and hypothesis. Neuroscience 12:347–375
Cox B, Ennis C (1982) Characterization of 5-hydroxytryptaminergic autoreceptors in the rat hypothalamus. J Pharm Pharmacol 34:438–441
Florvall L, Ask A-L, Ögren S-O, Ross SB (1978) Selective monoamine oxidase inhibitors. 1. Compounds related to 4-aminophenethylamine. J Med Chem 21:56–63
Florvall L, Kumar Y, Ask A-L, Fagervall I, Ross SB (1986a) Selective monoamine oxidase inhibitors. 3. Cyclic compounds related to 4-aminophenethylamine. Preparation and neuron-selective action of some 5-(2-aminoethyl)-2,3-dihydroindoles. J Med Chem 29:1406–1412
Florvall L, Fagervall I, Ask A-L, Ross SB (1986b) Selective monoamine oxidase inhibitors. 4. 4-Aminophenethylamine derivatives with neuron-selective action. J Med Chem 29:2250–2256
Fuller RW, Perry KW, Molloy BB (1975) Reversible and irreversible phases of serotonin depletion by 4-chloroamphetamine. Eur J Pharmacol 33:119–124
Fuller RW (1980) Mechanism by which uptake inhibitors antagonize p-chloroamphetamine-induced depletion of brain serotonin. Neurochem Res 5:241–245
Graefe K-H, Bönisch H (1988) The transport of amines across the axonal membranes of noradrenergic and dopaminergic neurones. In: Trendelenburg U, Weiner N (eds) Handbook of experimental pharmacology, vol 90/1. Springer, Berlin Heidelberg New York Tokyo, pp 193–245
Hyttel J (1978) Effects of a specific 5-HT uptake inhibitor, citalopram (LU 10–171), on 3H-5-HT uptake in rat brain synaptosomes in vitro. Psychopharmacology 60:13–18
Langeloh A, Trendelenburg U (1987) The mechanism of the 3H-noradrenaline-releasing effect of various substrates of uptake1: role of monoamine oxidase and of vesicularly stored 3H-noradrenaline. Naunyn-Schmiedeberg's Arch Pharmacol 336: 611–620
Langeloh A, Bönisch H, Trendelenburg U (1987) The mechanism of the 3H-noradrenaline-releasing effect of various substrates of uptake1: multifactorial induction of outward transport. Naunyn-Schmiedeberg's Arch Pharmacol 336:602–610
Meek JL, Fuxe K, Carlsson A (1971) Blockade of p-chloroamphetamine induced 5-hydroxytryptamine depletion by chlorimipramine, chlorpheniramine and meperidine. Biochem Pharmacol 20:707–709
Rényi L, Ross SB (1985) Effects of amiflamine and related compounds on the accumulation of biogenic monoamines in rat brain slices in vitro and ex vivo in relation to their behavioural effects. Acta Pharmacol Toxicol 56:416–426
Ross SB (1976) Antagonism of the acute and long-term biochemical effects of 4-chloroamphetamine on the 5-HT neurones in the rat brain by inhibitors of the 5-hydroxytryptamine uptake. Acta Pharm Toxicol 39:456–476
Ross SB, Ask A-L (1980) Structural requirements for uptake into serotonergic neurones. Acta Pharmacol Toxicol 46:270–277
Ross SB, Kelder D (1977) Efflux of 5-hydroxytryptamine from synaptosomes of rat cerebral cortex. Acta Physiol Scand 99:27–36
Sanders-Bush E, Steranka LR (1978) Immediate and long-term effects of p-chloroamphetamine on brain amines. Ann NY Acad Sci 305:208–221
Sanders-Bush E, Martin LL (1982) Storage and release of serotonin. In: Osborne NN (ed) Biology of serotonergic transmission. John Wiley, New York, pp 95–118
Wong DT, Horng JS, Fuller RW (1973) Kinetics of serotonin accumulation into synaptosomes of rat brain: Effects of amphetamine and chloroamphetamines. Biochem Pharmacol 22:311–322
Author information
Authors and Affiliations
Additional information
Send offprint requests to A.-L. Ask at the above address
Rights and permissions
About this article
Cite this article
Ask, AL., Fagervall, I., Huang, RB. et al. Release of 3H-5-hydroxytryptamine by amiflamine and related phenylalkylamines from rat occipital cortex slices. Naunyn-Schmiedeberg's Arch Pharmacol 339, 684–689 (1989). https://doi.org/10.1007/BF00168662
Received:
Accepted:
Issue date:
DOI: https://doi.org/10.1007/BF00168662


